For people living with chronic lung conditions, clearing mucus from the airways is a critical part of staying healthy. Diseases such as cystic fibrosis (CF), bronchiectasis, neuromuscular disorders, and certain forms of chronic obstructive pulmonary disease (COPD) can cause thick mucus to build up in the lungs. When mucus is not cleared effectively, it can block airflow and lead to repeated lung infections.
High-frequency chest wall oscillation, often called HFCWO, is a therapy designed to help move mucus out of the lungs. It has been used for many years and is recommended by clinical guidelines for people who need regular airway clearance. In recent years, new wearable versions of this therapy, such as the AffloVest, have been developed to make treatment easier to use in everyday life.
How HFCWO Works
HFCWO works by gently vibrating the chest at a rapid rate. These vibrations travel through the chest wall and into the lungs, helping to loosen mucus that sticks to the airway walls. As the mucus becomes thinner and more mobile, it is easier to move toward the larger airways, where it can be coughed out or removed with suction if needed.
The vibrations also help push air through the lungs in a way that favors mucus moving upward, toward the mouth. This process does not depend on strong breathing or coughing from the patient. Instead, the device provides the movement externally.
Because of this, HFCWO can be especially helpful for people who feel too tired or short of breath to perform active breathing exercises. It is also valuable for individuals with muscle weakness, including those with neuromuscular conditions, who may have difficulty generating an effective cough on their own.
Evidence That HFCWO Is Helpful
HFCWO has been studied in many different lung conditions. In people with cystic fibrosis, research has shown that it works as well as traditional chest physical therapy for clearing mucus and maintaining lung function. Many patients also find it easier to manage on their own, without needing a caregiver.
The use of HFCWO has expanded beyond cystic fibrosis. In people with bronchiectasis who produce large amounts of mucus or experience frequent lung infections, studies show that regular use of HFCWO can reduce symptoms and lower the number of hospital visits related to breathing problems. For people with COPD who have chronic bronchitis and daily mucus production, HFCWO is often used alongside medications. Research suggests it can help loosen mucus, improve comfort, and sometimes shorten hospital stays during flare-ups. While lung function tests may not always change, many patients report feeling less congested and breathing more comfortably.
HFCWO is also commonly used in people with neuromuscular diseases. In these conditions, clearing mucus can be especially challenging. HFCWO helps move secretions without requiring extra effort, which can reduce the risk of lung infections and breathing complications.
Across all of these conditions, one important factor stands out: the therapy works best when people use it consistently. Comfort, convenience, and how well the treatment fits into daily life all play a major role in whether someone sticks with it long term.
Challenges With Traditional HFCWO Devices
Traditional HFCWO systems typically involve a large machine connected by hoses to an inflatable vest. During treatment, patients must stay in one place while the machine runs. For some people, this setup can feel bulky, time-consuming, or disruptive. These challenges may not seem major at first, but over time they can make it harder to use the therapy every day. For people who work, care for others, or manage multiple health issues, setting aside time to remain connected to stationary equipment can be a real barrier.
What Makes the AffloVest Different
The AffloVest is a newer type of HFCWO device designed to reduce many of these barriers. Instead of using air hoses and an external machine, it contains small vibration units built directly into the vest. The system is battery powered and fully wearable. This design allows people to move around during treatment. They can walk, perform light activities, or simply avoid being tied to one spot. For many users, this flexibility makes it easier to fit therapy into daily routines.
The vest is also designed to fit more closely to the body and apply vibrations in specific areas of the chest. This may improve comfort for some users, especially those who find traditional vests heavy or awkward. Importantly, the AffloVest still delivers the same type of therapy as traditional systems. It simply does so in a more portable form.
Choosing the Right Therapy
Not everyone needs HFCWO, and it is not the right solution for every patient. Doctors typically recommend it for people who have daily mucus buildup, frequent lung infections, or difficulty using other airway clearance techniques.
Wearable systems like the AffloVest may be especially helpful for people who struggled to keep up with therapy in the past due to scheduling, mobility, or lifestyle challenges. As with any treatment, the best choice depends on individual needs, preferences, and medical guidance.
HFCWO is often used alongside other treatments, such as inhaled medications that open the airways or thin mucus. Education and follow-up with healthcare providers help ensure the therapy is being used correctly and effectively.
Conclusion
High-frequency chest wall oscillation is a well-established therapy that helps people with chronic lung conditions clear mucus from their airways. It has been shown to support breathing comfort and reduce complications across a range of diseases.
While traditional systems are effective, newer wearable devices like the AffloVest offer added flexibility and convenience. By making therapy easier to use in everyday life, these innovations may help more people stay consistent with treatment, which is an essential factor in long-term lung health.
References:
Leemans, Glenn et al. “The effectiveness of a mobile high-frequency chest wall oscillation (HFCWO) device for airway clearance.” Pediatric pulmonology vol. 55,8 (2020): 1984-1992. doi:10.1002/ppul.24784
Volpe, Marcia S et al. “Ventilation patterns influence airway secretion movement.” Respiratory care vol. 53,10 (2008): 1287-94.
Morrison, Lisa, and Stephanie Innes. “Oscillating devices for airway clearance in people with cystic fibrosis.” The Cochrane database of systematic reviews vol. 5,5 CD006842. 4 May. 2017, doi:10.1002/14651858.CD006842.pub4
Gipsman, Alexander Ilan et al. “Airway clearance in patients with neuromuscular disease.” Paediatric respiratory reviews vol. 47 (2023): 33-40. doi:10.1016/j.prrv.2023.02.002
Urribarri, Martha E. Camacho, Brian C. Becker, and Angela C. Murray. "Impact of High-Frequency Chest Wall Oscillation on Health Care Resource Use and Economic Outcomes in Adult Patients With Non-Cystic Fibrosis Bronchiectasis in the United States: A Pre-Post Cohort Analysis." CHEST Pulmonary 2.1 (2024): 100013.
Ge, Jiaqi, et al. "High-frequency chest wall oscillation multiple times daily can better reduce the loss of pulmonary surfactant and improve lung compliance in mechanically ventilated patients." Heart & Lung 61 (2023): 114-119.
LEGAL DISCLAIMER: Material in this newsletter is provided for general health education and informational purposes and to provide references to other resources only; it may not apply to you as an individual. While Apria Healthcare believes that the information provided through this communication is accurate and reliable, Apria Healthcare cannot and does not make any such guarantee. It is not intended to be a replacement for professional medical advice, evaluation, diagnosis, services or treatment (collectively, “medical treatment”). Please see your healthcare provider for medical treatment related to you and your specific health condition(s). Never disregard medical advice or delay seeking medical care because of something you have read on or accessed through this website. Reading this newsletter should not be construed to mean that you have a healthcare provider/patient relationship.
.png)
